Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ionis Pharmaceuticals 2855 GAZELLE COURT CARLSBAD CA 92010 USA

https://ionis.com Employees: 1,402 P: 760-931-9200

Sector:

Medical

Description:

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Key Statistics

Overview:

Market Capitalization, $K 12,230,816
Enterprise Value, $K 12,318,626
Shares Outstanding, K 165,192
Float, K 160,897
% Float 97.40%
Short Interest, K 15,488
Short Float 9.38%
Days to Cover 8.37
Short Volume Ratio 0.84
% of Insider Shareholders 2.60%
% of Institutional Shareholders 93.86%

Financials:

Annual Sales, $ 943,710 K
Annual Net Income, $ -381,390 K
Last Quarter Sales, $ 203,330 K
Last Quarter Net Income, $ -229,390 K
EBIT, $ -381,680 K
EBITDA, $ -375,810 K

Growth:

1-Year Return 122.89%
3-Year Return 118.02%
5-Year Return 39.72%
5-Year Revenue Growth 29.41%
5-Year Earnings Growth 26.32%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.41 on 02/25/26
Next Earnings Date 04/29/26
Earnings Per Share ttm -2.44
EPS Growth vs. Prev Qtr -76.25%
EPS Growth vs. Prev Year -113.64%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IONS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.82%
Return-on-Assets % -12.34%
Profit Margin % -40.41%
Debt/Equity 0.94
Price/Sales 13.15
Price/Cash Flow N/A
Price/Book 24.89
Book Value/Share 3.02
Interest Coverage -3.19
60-Month Beta 0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar